{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:39:46Z","timestamp":1790811586392,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:p>Activation of the mineralocorticoid receptor has been shown to be deleterious in cardiovascular diseases (CVDs). We have recently shown that lipocalin 2 (Lcn2), or neutrophil gelatinase\u2013associated lipocalin (NGAL), is a primary target of aldosterone\/mineralocorticoid receptor in the cardiovascular system. Lcn2 is a circulating protein, which binds matrix metalloproteinase 9 and modulates its stability. We hypothesized that Lcn2 could be a mediator of aldosterone\/mineralocorticoid receptor profibrotic effects in the cardiovascular system. Correlations between aldosterone and profibrotic markers, such as procollagen type I N-terminal peptide, were investigated in healthy subjects and subjects with abdominal obesity. The implication of Lcn2 in the mineralocorticoid pathway was studied using Lcn2 knockout mice subjected to a nephrectomy\/aldosterone\/salt (NAS) challenge for 4 weeks. In human subjects, NGAL\/matrix metalloproteinase 9 was positively correlated with plasma aldosterone and fibrosis biomarkers. In mice, loss of Lcn2 prevented the NAS-induced increase of plasma procollagen type I N-terminal peptide, as well as the increase of collagen fibers deposition and collagen I expression in the coronary vessels and the aorta. The lack of Lcn2 also blunted the NAS-induced increase in systolic blood pressure. Ex vivo, treatment of human fibroblasts with recombinant Lcn2 induced the expression of collagen I and the profibrotic galectin-3 and cardiotrophin-1 molecules. Our results showed that Lcn2 plays a key role in aldosterone\/mineralocorticoid receptor\u2013mediated vascular fibrosis. The clinical data indicate that this may translate in human patients. Lcn2 is, therefore, a new biotarget in cardiovascular fibrosis induced by mineralocorticoid activation.<\/jats:p>","DOI":"10.1161\/hypertensionaha.115.05431","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T02:51:10Z","timestamp":1432003870000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":98,"title":["Neutrophil Gelatinase\u2013Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids"],"prefix":"10.1161","volume":"66","author":[{"given":"Antoine","family":"Tarjus","sequence":"first","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Amador","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Latouche","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"El Moghrabi","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Berger","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak W.","family":"Mak","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Fay","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Farman","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"L\u00f3pez-Andr\u00e9s","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Jaisser","sequence":"additional","affiliation":[{"name":"From the INSERM UMR 1138 Team 1, Centre de Recherche des Cordeliers, Universit\u00e9 Pierre et Marie Curie, Paris, France (A.T., C.A., C.L., S.E.M., N.F., F.J.); NAVARRABIOMED\u2014FUNDACI\u00d3N MIGUEL SERVET, Pamplona, Spain (E.M.-M., N.L.-A.); The Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON, Canada (T.B., T.W.M.); INSERM, Centre d\u2019Investigations Cliniques-Plurith\u00e9matique 1433, CHU de Nancy, France (R.F., P.R., F.Z., N.L.-A., F.J.); Universit\u00e9 de Lorraine, Nancy, France ..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.06.038"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009492"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.187872"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080882"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.103267"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2012.03.008"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M106089200"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)81511-J"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2011.61"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.075614"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-009-0486-8"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1073154"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803508"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000154361.47683.d3"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02419"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.809194"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510847103"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01967"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-147926"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.153619"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01587.x"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300569"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00283.2011"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp088"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0633"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066607"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303486"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303718"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.198986"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.229070"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2010.549276"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2013.863320"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.115.05431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:07:26Z","timestamp":1715591246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.115.05431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.115.05431"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.115.05431","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"2015-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-03-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-05-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}